-
complex biology research experiments. As a successful candidate, you will: Characterize engineered natural killer (NK) cells and patient samples. Possess pathology knowledge and proficiency in various
-
technology and contribute to groundbreaking discoveries in cancer and related diseases. For more information on Dr. Saul Priceman’s research, please visit here . As a successful candidate, you will: Conduct
-
specific to the RefleXion linear accelerator. RefleXion is a novel radiation machine that delivers treatment using positron emission tomography (PET) guidance. As it is a new technology and our program is
-
edge technology, research and clinical immunotherapeutic programs. New personnel will be trained in project specific techniques and procedures. As a successful candidate, you will: · Manufacture
-
to groundbreaking projects, employing high-throughput CRISPR genetic screening to unveil novel targets and utilizing single-cell technology for in-depth genome analysis in hematological malignancies. You will also
-
edge technology, research and clinical immunotherapeutic programs. New personnel will be trained in project specific techniques and procedures. As a successful candidate, you will: · Manufacture
-
-paced lab involved in cutting edge technology, research and clinical immunotherapeutic programs. New personnel will be trained in project specific techniques and procedures. As a successful candidate
-
leukemogenesis as well as disease relapse in order to design novel inhibitors to intervene the malignancies · Collaborative analyses of myeloid cancers genomics using high-throughput single-cell technology
-
are seeking a fast-paced academic research environment. Our lab in the Department of Immuno-Oncology focuses on engineering tumor-colonizing bacteria to target components of the tumor microenvironment
-
and identification of HLA-restricted epitopes derived from them As a successful candidate, you will: · Work with both genetically engineered mouse models, patient-derived AML xenograft models